SCHEMBL9647147

SCHEMBL9647147

O=C(C(=O)c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 6/20 0.74
CES1 P23141 5/20 0.74
SMN1; SMN2 Q16637 4/20 0.65
MAPT P10636 3/20 0.65
RAB9A P51151 3/20 0.60
NPC1 O15118 1/20 0.60
CTDSP1 Q9GZU7 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.58
PTPN1 P18031 1/20 0.58
GSK3B P49841 1/20 0.58
LMNA P02545 2/20 0.56
CDC25B P30305 1/20 0.56
ATM Q13315 1/20 0.56
FFAR1 O14842 1/20 0.56
CYP1A2 P05177 1/20 0.56
HIF1A Q16665 1/20 0.56
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
HPGD P15428 1/20 0.54
ERCC5 P28715 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14211984 0.97 CES2 (0.79) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL11312963 0.94 CES2 (0.83) CES2CES1SMN1; SMN2MAPTRAB9A
Benzil SCHEMBL301947 0.92 CES2 (0.82) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL14124772 0.90 SMN1; SMN2 (0.60) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL7746452 0.90 SMN1; SMN2 (0.60) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL11315479 0.89 KMO (0.67) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL17652903 0.89 CES2 (0.70) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL9647503 0.89 CES2 (0.79) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL13569209 0.87 CES2 (0.57) CES2CES1SMN1; SMN2MAPTRAB9A
SCHEMBL3795547 0.87 KMO (0.64) CES2CES1SMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122028797-A Double-stranded RNA methods and compositions for pesticides 核糖核酸复兴股份有限责任公司 2026-05-12 CN disclosed
CN-119708013-A Organic luminescent material and preparation method and application thereof 武汉尚赛光电科技有限公司 2025-03-28 CN disclosed
US-12161047-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION 2024-12-03 US disclosed
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 US disclosed
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2023-02-23 US disclosed
US-11508913-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-11-22 US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 US disclosed
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 US disclosed
US-8501901-B2 Material for photovoltaic device, and photovoltaic device TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
US-8501901-B2 Material for photovoltaic device, and photovoltaic device TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
US-20110272030-A1 MATERIAL FOR PHOTOVOLTAIC DEVICE, AND PHOTOVOLTAIC DEVICE TORAY INDUSTRIES, INC. (JP) 2011-11-10 US disclosed
US-7626059-B2 Multifunctional ethynyl substituted monomers and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES INC. 2009-12-01 US disclosed
US-20090012193-A1 Multifunctional Ethynyl Substituted Monomers and Polyarylene Compositions Therefrom DOW GLOBAL TECHNOLOGIES LLC 2009-01-08 US disclosed
US-7355340-B2 Quinoxaline derivatives, organic semiconductor device and electroluminescent device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-04-08 US disclosed
US-7355340-B2 Quinoxaline derivatives, organic semiconductor device and electroluminescent device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-04-08 US disclosed
EP-0362638-B1 METHOD OF PREPARING SYMMETRICAL AND UNSYMMETRICAL MONOACETALS OF AROMATIC 1,2-DIKETONES BASF Aktiengesellschaft (DE) 1992-12-02 EP disclosed
EP-0362638-A2 Method of preparing symmetrical and unsymmetrical monoacetals of aromatic 1,2-diketones BASF Aktiengesellschaft (DE) 1990-04-11 EP disclosed
US-4287367-A Manufacture of symmetrical or unsymmetrical monoacetals of aromatic 1,2-diketones BASF AKTIENGESELLSCHAFT (DE) 1981-09-01 US disclosed
US-4190602-A PHOTOCHEMICAL SENSITIZERS BY REACTION OF SULFUROUS ACID ESTER OR THIONYL CHLORIDE AND A PRIMARY ALCOHOL CIBA-GEIGY CORPORATION (US) 1980-02-26 US disclosed
US-4144156-A Manufacture of unsymmetric monoacetals of aromatic 1,2-diketones employable as photoiniatiators BASF AKTIENGESELLSCHAFT (DE) 1979-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012193-A1 Multifunctional Ethynyl Substituted Monomers and Polyarylene Compositions Therefrom WEE2, WASF2, WEE1 CES2 178/4885CES1 1663/4885SMN1; SMN2 4353/4885
US-11508913-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OXA1L CES2 529/4885CES1 956/4885SMN1; SMN2 3847/4885
US-12161047-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OXA1L CES2 529/4885CES1 956/4885SMN1; SMN2 3847/4885
US-20230057590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 CES2 800/4885CES1 2041/4885SMN1; SMN2 2771/4885
US-20190051842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OXER1 CES2 800/4885CES1 2041/4885SMN1; SMN2 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.